Translational Results of Zo-NAnTax: A Phase II Trial of Neoadjuvant Zoledronic Acid in HER2-Positive Breast Cancer

Breast cancer is a heterogeneous disease with distinct clinical and molecular characteristics. Scientific advances in molecular subtype differentiation support the understanding of cellular signaling, crosstalk, proliferation, survival, migration, and invasion mechanisms, allowing the development of...

Descripción completa

Detalles Bibliográficos
Autores principales: Crocamo, Susanne, Binato, Renata, dos Santos, Everton Cruz, de Paula, Bruno, Abdelhay, Eliana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779412/
https://www.ncbi.nlm.nih.gov/pubmed/36555156
http://dx.doi.org/10.3390/ijms232415515

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779412/
https://www.ncbi.nlm.nih.gov/pubmed/36555156
http://dx.doi.org/10.3390/ijms232415515

Ejemplares similares